Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of MAPK3 (phospho T202/Y204) polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse,Rat |
| Host species | Rabbit |
| Applications | WB-Ce |
More info about MAPK3 (phospho T202/Y204) polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB1250 |
| Product name: | MAPK3 (phospho T202/Y204) polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic phosphopeptide of MAPK3. |
| Gene id: | 5595 |
| Gene name: | MAPK3 |
| Gene alias: | ERK1|HS44KDAP|HUMKER1A|MGC20180|P44ERK1|P44MAPK|PRKM3 |
| Gene description: | mitogen-activated protein kinase 3 |
| Immunogen: | Synthetic phosphopeptide (conjugated with KLH) corresponding to residues surrounding T202/Y204 of human MAPK3. |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:5000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In HEPES, 150 mM NaCl (50% glycerol, 0.01% BSA, 0.03% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human,Mouse,Rat |
| Application image: |  |
| Application image note: | Immunoblot analysis of NIH/3T3 cell lysates stimulated with PDGF. (* N.S : Nonspecific band) |
| Applications: | WB-Ce |
| Shipping condition: | Dry Ice |
| Publications: | Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.Kolch W. Biochem J. 2000 Oct 15;351 Pt 2:289-305. |